Χώρα: Σιγκαπούρη
Γλώσσα: Αγγλικά
Πηγή: HSA (Health Sciences Authority)
CALCIUM CHLORIDE DIHYDRATE; ICODEXTRIN; MAGNESIUM CHLORIDE HEXAHYDRATE; SODIUM CHLORIDE; SODIUM LACTATE
VANTIVE PTE. LTD.
B05DA
257 mg/l
SOLUTION, STERILE
CALCIUM CHLORIDE DIHYDRATE 257 mg/l; ICODEXTRIN 75 g/l; MAGNESIUM CHLORIDE HEXAHYDRATE 50.8 mg/l; SODIUM CHLORIDE 5.38 g/l; SODIUM LACTATE 4.48 g/l
INTRAPERITONEAL
General Sale List
BAXTER HEALTHCARE SA, SINGAPORE BRANCH
ACTIVE
1999-11-09
EXTRANEAL PERITONEAL DIALYSIS SOLUTION WITH 7.5% ICODEXTRIN FOR INTRAPERITONEAL ADMINISTRATION ONLY PRODUCT NAME EXTRANEAL (ICODEXTRIN 7.5%) COMPOSITION EXTRANEAL is a sterile solution for intraperitoneal administration. Each 100 ml of EXTRANEAL contains: Electrolyte solution content per 1000 ml: Icodextrin 7.5 g Sodium 132 mmol Sodium Chloride 538 mg Calcium 1.75 mmol Sodium Lactate 448 mg Magnesium 0.25 mmol Calcium Chloride 25.7 mg Chloride 96 mmol Magnesium Chloride 5.08mg Lactate 40 mmol Theoretical osmolarity 284 (milliosmoles per litre). COMPOSITION IN FULL EXTRANEAL also contains: Water for injections. PHARMACEUTICAL FORM AND PHARMACOLOGICAL PROPERTIES EXTRANEAL is a sterile peritoneal dialysis fluid containing Icodextrin as the active ingredient at a concentration of 7.5%, in an electrolyte solution. It should not be used for intravenous administration. EXTRANEAL is presented in flexible PVC containers and is available in the following bag sizes: Code Fill Volume (mL) Container Size (mL) Product Configuration Pack Size FNB4974 2000 2000 AMBU-FLEX 6 FNB4982 1500 2000 ULTRABAG 8 FNB4984 2000 2000 ULTRABAG 6 PRECLINICAL SAFETY DATA Carcinogenesis, Mutagenesis, Impairment of Fertility Icodextrin did not demonstrate evidence Διαβάστε το πλήρες έγγραφο
➀ 16-1540_PPD-25-245 Extraneal PL-path.indd 1 25/7/16 16:46 CLINICAL TRIAL ADVERSE REACTIONS † SYSTEM ORGAN CLASS (SOC) PREFERRED MEDDRA TERM FREQUENCY* FREQUENCY PERCENTAGE OR RATIO N=493 ➁ 16-1540_PPD-25-245 Extraneal PL-path.indd 2 25/7/16 16:46 CLINICAL TRIAL ADVERSE REACTIONS † SYSTEM ORGAN CLASS (SOC) PREFERRED MEDDRA TERM FREQUENCY* FREQUENCY PERCENTAGE OR RATIO N=493 ➂ 16-1540_PPD-25-245 Extraneal PL-path.indd 3 25/7/16 16:46 Διαβάστε το πλήρες έγγραφο